Brief: Alpha Tau Receives FDA Approval To Initiate A Trial For Patients With Locally Recurrent Prostate Cancer

Alpha Tau Medical

02/12/2025 14:14

Dec 2 (Reuters) - Alpha Tau Medical Ltd DRTS.O:

ALPHA TAU RECEIVES FDA APPROVAL TO INITIATE A TRIAL FOR PATIENTS WITH LOCALLY RECURRENT PROSTATE CANCER

Source text: ID:nGNX1rc016

Further company coverage: DRTS.O

 ((Reuters.Briefs@thomsonreuters.com;))